MiMedx GroupMDXG

那斯達克 · USD
7.25
+0.13
(+1.83%)
收盤 12/17 04:59 (UTC+8)
12/17 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.81
  • 0.82
  • 0.87
  • 0.85
  • 0.87
  • 0.84
  • 0.93
  • 0.88
  • 0.99
  • 1.14
icon
  • 13.37
  • 0.56
  • 6.27
  • -2.44
  • 2.95
  • -3.61
  • 10.53
  • -5.06
  • 11.79
  • 15.33
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
113,725
98,605
88,205
92,907
84,057
87,206
84,709
86,832
81,712
81,257
營業成本
18,71918,68116,55816,90915,32314,85412,98713,84214,79013,583
營業毛利
95,006
79,924
71,647
75,998
68,734
72,352
71,722
72,990
66,922
67,674
營業費用
72,81667,55563,39664,944---57,50067,19867,924
研發費用
3,7043,3043,3283,5712,9183,0112,8412,43311,01211,509
推銷及管理費用
69,00164,15159,96961,04353,51455,40155,12954,35152,57051,952
非經常性項目費用
---137947-9,7013655243,4264,273
其他營業費用
11110099193193190189192190190
營業利益
22,190
12,369
8,251
11,054
11,162
23,451
13,198
15,490
-276
-250
其他收入及費用
-125-102-145-208-21-237-9916-10-34
利息費用
---1,006--1,6906,4574,8641,631
稅前純益
22,850
13,005
8,612
11,249
11,419
23,217
11,409
13,913
-1,966
-1,915
所得稅
6,1023,3891,5893,8113,5415,5962,348-37,375592-74
稅後純益
16,748
9,616
7,023
7,438
8,095
17,625
9,261
53,477
8,534
1,200
基本每股稅後盈餘(元)
0.110.070.050.050.050.120.06-0.060.00
稀釋每股稅後盈餘(元)
0.110.060.050.050.050.120.060.370.060.00
基本平均股數(千股)
148035.00147761.00147272.00147008.00146958.00147326.00146404.00-116298.00115866.00
稀釋平均股數(千股)
149713.00149317.00149677.00149242.00148373.00148897.00150028.00-149773.00146862.00
還原基本每股稅後盈餘(元)
0.110.070.050.050.050.120.06-0.060.00
還原稀釋每股稅後盈餘(元)
0.110.060.050.050.050.120.060.370.060.00
還原基本平均股數(千股)
148,035147,761147,272147,008146,958147,326146,404-116,298115,866
還原稀釋平均股數(千股)
149,713149,317149,677149,242148,373148,897150,028-149,773146,862
EBITDA(千元)
28,14016,01411,97415,24513,01024,27914,13723,58715,2763,779

大家都在看

HOT